🇺🇸 PFE — Pfizer Inc.

Healthcare Compra
← Volver

Precio actual

27,79 USD

Máx. histórico

61,71

1723 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-54,97%

Rango 52 semanas

23,58 – 29,21

Variación hoy

-2,32%

Cierre anterior

28,45

Rango de hoy

27,72 – 28,15

Volumen hoy

31.727.745

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
36,57 (puede no estar actualizado)
Dividend yield
6,05% (puede no estar actualizado)
Precio objetivo analistas
28,61 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 3 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 6,19%
Fecha de pago Importe por participación
05/03/1974 0,0034 USD
27/11/1973 0,0043 USD
28/08/1973 0,0032 USD
30/05/1973 0,0032 USD
28/02/1973 0,0032 USD
28/11/1972 0,0042 USD
29/08/1972 0,0032 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/05/2002 34,63 34,89 34,12 34,36 -0,77% 2,22% 11.574.079
09/05/2002 34,96 35,22 34,49 34,63 -1,80% 2,09% 9.286.794
08/05/2002 33,97 35,58 33,93 35,27 +3,97% 4,86% 15.316.306
07/05/2002 35,01 35,19 33,84 33,92 -2,19% 3,85% 14.316.798
06/05/2002 35,10 35,21 34,50 34,68 -0,54% 2,03% 7.556.969
03/05/2002 35,39 35,44 34,39 34,87 -1,66% 2,95% 11.172.295
02/05/2002 35,58 35,91 35,35 35,46 -0,24% 1,57% 13.012.579
01/05/2002 34,82 35,71 34,66 35,54 +3,05% 3,02% 16.730.353
30/04/2002 34,72 35,14 34,06 34,49 +0,22% 3,11% 22.780.734
29/04/2002 35,05 35,05 34,03 34,41 -1,33% 2,90% 12.567.685
26/04/2002 35,72 35,81 34,87 34,88 -2,16% 2,63% 18.514.880
25/04/2002 36,43 36,43 35,53 35,65 +2,96% 2,47% 22.971.825
24/04/2002 34,83 35,16 34,49 34,62 -0,57% 1,93% 11.399.853
23/04/2002 35,16 35,28 34,63 34,82 -1,10% 1,83% 16.401.399
22/04/2002 36,05 36,07 34,88 35,21 -1,83% 3,32% 17.448.127
19/04/2002 36,10 36,29 35,72 35,86 -1,10% 1,58% 14.589.468
18/04/2002 36,29 36,64 36,10 36,26 +0,98% 1,49% 21.134.703
17/04/2002 37,10 37,29 35,52 35,91 -5,14% 4,76% 43.579.211
16/04/2002 37,16 37,95 37,03 37,86 +2,31% 2,48% 12.590.979
15/04/2002 36,95 37,14 36,62 37,00 -0,74% 1,41% 9.964.094
12/04/2002 36,82 37,42 36,82 37,28 +1,00% 1,62% 12.561.572
11/04/2002 37,15 37,60 36,76 36,91 -1,12% 2,25% 14.395.954
10/04/2002 36,53 37,46 36,53 37,32 +1,65% 2,55% 13.695.887
09/04/2002 36,59 36,93 36,31 36,72 +0,60% 1,69% 13.382.111
08/04/2002 35,63 36,62 35,63 36,50 +1,24% 2,80% 17.169.028
05/04/2002 37,10 37,23 35,72 36,05 -2,56% 4,07% 27.456.700
04/04/2002 37,50 37,62 36,92 37,00 -2,50% 1,87% 19.820.154
03/04/2002 37,99 38,13 37,64 37,95 +0,23% 1,30% 11.707.305
02/04/2002 38,06 38,24 37,72 37,87 -0,50% 1,35% 9.364.474
01/04/2002 37,62 38,19 37,58 38,06 +0,93% 1,61% 8.189.791